Sacramento, CA27 Active Studies

Erectile Dysfunction Clinical Trials in Sacramento, CA

Find 27 actively recruiting erectile dysfunction clinical trials in Sacramento, CA. Connect with local research sites and explore new treatment options.

27
Active Trials
23
Sponsors
10,482
Enrolling

Recruiting Erectile Dysfunction Studies in Sacramento

About Erectile Dysfunction Clinical Trials in Sacramento

Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.

There are currently 27 erectile dysfunction clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 10,482 participants. Research is being sponsored by American Society of Clinical Oncology, Biotest, AbbVie and 20 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Erectile Dysfunction Clinical Trials in Sacramento — FAQ

Are there erectile dysfunction clinical trials in Sacramento?

Yes, there are 27 erectile dysfunction clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What erectile dysfunction treatments are being tested?

The 27 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.

Data updated July 17, 2026 from ClinicalTrials.gov